Fulgent provides comprehensive NGS-based clinical and research sequencing services with competitive prices and fast turnaround times.
Our team consists of bioinformaticians and scientists who are pioneers in the field of NGS-based genetic testing, equipping Fulgent with the knowledge and experience to push us to the forefront of science and technology. Our state-of-the-art sequencing platforms give us tremendous sequencing capacity, ensuring that we can handle projects of all size and scale.
As a CLIA-certified and CAP-accredited clinical laboratory, we adhere to the strictest quality control standards in the industry. All samples that we receive undergo several QC checks throughout the laboratory process, starting from before extraction and continuing through the library, sequencing, and post-sequencing phases.
We utilize sophisticated barcoding and tag systems to track each sample and prevent sample mix-up, and we follow a unidirectional workflow that is highly integrated with our in-house developed laboratory information management system (LIMS) to ensure that every sample is tracked and handled proficiently. If you have any questions about quality standards, please contact us at SeqService@fulgentgenetics.com
We have a very streamlined and highly automated laboratory workflow, which ensures that we can deliver clinical-grade quality at very competitive turnaround times.
All samples follow the same general flow, which begins with accessioning the sample, and then proceeding with extraction -> library prepartion -> sequencing -> analysis. Once results are ready, they will be delivered via secure FTP.
As a laboratory built around NGS-technology we offer an impressive array of state-of-the-art sequencing platforms – each designed for different sequencing needs and applications. Our broad suite of sequencers ensures that we can provide affordable, fast, and high-quality sequencing services for diverse projects of virtually any scale.
Our CLIA-validated WES services for FFPE specimens are designed for clinical trials, clinical diagnostics, and for researchers involved in clinical research. In addition, we offer standard data analysis options for WES - including mapping, alignment, somatic variant calling and annotation.
Our CLIA-validated RNA sequencing services for FFPE specimens are designed for clinical trials, clinical diagnostics, and for researchers involved in clinical research. In addition, we offer standard data analysis options for RNA-Seq - including mapping, alignment, variant calling, and gene expression analysis.
Fulgent offers clinically validated Solid Tumor Molecular Profiling services from FFPE specimen using Illumina’s TST-170 kit. DNA and RNA are sequenced and analyzed in parallel.
Didn't find exactly what you were looking for? We offer the option to rent a variety of state-of-the-art sequencing platforms, allowing you to customize sequencing projects depending on your specific needs. You can select from Illumina NovaSeq, HiSeq4000, and MiSeq – each of which is designed for different sequencing applications.